In the inflamed mucosa of IBD patients, there is an observed imbalance between IL-1 and its antagonist IL-1Ra, with increased levels of both, but a significantly decreased ratio of IL-1Ra to IL-1 compared to controls. The gene discussed is IL1A; the disease is inflammatory bowel disease.